Genoptix Company Profile

04:29 EDT 19th March 2018 | BioPortfolio

Genoptix has developed a breadth of services that focus on the challenges of each phase of patient management to help in effective diagnosis, optimal treatment decisions and monitoring of hematopoietic diseases. We partner with community-based hematologist/oncologists to help them deliver the best possible personalized medicine.

Genoptix COMPASS™ (Comprehensive Assessment) Services
A hematopathology service for blood and bone marrow samples that includes morphology, 6-color flow cytometry, cytogenetics and PCR, as needed, for fully integrated diagnostic intelligence that is presented in a concise and clear reporting format.
This allows Genoptix to move forward in helping physicians set unprecedented standards for personalized patient management through:

• Accurate diagnosis
• More effective treatment
• Reduced adverse events
• Enhanced monitoring
• Improved outcomes

Additionally, our exclusive CancerTRAX® analysis examines individual response to chemotherapeutic agents in chronic lymphocytic leukemia (CLL), providing direction for clinical management.


2110 Rutherford Rd
United States of America


Phone: 760.268.6200
Fax: 760.268.6201

News Articles [9 Associated News Articles listed on BioPortfolio]

Rosetta Genomics to be acquired by Genoptix in $10M deal

Rosetta Genomics will be acquired by hematology and solid tumor molecular profiling provider Genoptix under a $10 million all -More- 

Genoptix plans to acquire Rosetta Genomics for $10mm in cash; transaction later terminated

Oncology diagnostic lab Genoptix Inc. agreed to acquire all outstanding shares of Nasdaq-traded Israeli genomics company Rosetta Genomics Ltd. (cancer diagnostics).

Rosetta Genomics Ltd.: Genoptix Enters into Agreement to Market and Distribute Rosetta Genomics' Testing Services Worldwide

Genoptix Will Have Exclusive Distribution Rights in the U.S. and Non-exclusive Rights in Most Geographies Outside the U.S. CARLSBAD, CA, PHILADELPHIA, PA and REHOVOT, ISRAEL / ACCESSWIRE / March 13...

Rosetta Genomics Ltd.: Rosetta Genomics Announces Results from Extraordinary General Meeting of Shareholders to Vote on Proposed Merger with Genoptix

Although shares voted were more than 2-to-1 in favor of the merger, the proposal failed to secure a majority of shares outstanding Company considering alternative options with Genoptix LAKE FOREST...

Rosetta Genomics Ltd.: Genoptix Completes Acquisition of PersonalizeDx from Rosetta Genomics

-First step in the process of Genoptix acquiring all of Rosetta Genomics -Next step is the completion of a merger for $8 million in cash pursuant to which value to Rosetta Genomics' equity holders...

Rosetta Genomics Ltd.: Genoptix to Acquire Rosetta Genomics for $10 Million in Cash

The value to Rosetta Genomics' equity holders is preliminarily estimated to be $0.60 per ordinary share, after deductions for debt, warrant termination payments, fees, expenses and other items CAR...

Rosetta Genomics Ltd.: Rosetta Genomics Urges Shareholders to Vote FOR the Proposed Merger with Genoptix

Shares voted to date are running 3-to-1 in favor of the merger Emphasizes that shareholders as of December 27, 2017, regardless of whether or not they still hold their shares, are entitled to vote...

Rosetta Genomics Ltd.: Rosetta Sets a New Date for Shareholder Meeting to Approve Genoptix Merger

Previously announced meeting date of April 6, 2018, for its extraordinary general meeting of shareholders, has been cancelled and rescheduled for April 17, 2018 New record date for shareholder mee...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [2 Associated Companies listed on BioPortfolio]

Genoptix, Inc.

Genoptix is a leading specialized laboratory service provider focused on delivering personalized and comprehensive diagnostic services to its physician customers, community-based hematologists and onc...


Genoptix has developed a breadth of services that focus on the challenges of each phase of patient management to help in effective diagnosis, optimal treatment decisions and monitoring of hematopoieti...

More Information about "Genoptix" on BioPortfolio

We have published hundreds of Genoptix news stories on BioPortfolio along with dozens of Genoptix Clinical Trials and PubMed Articles about Genoptix for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Genoptix Companies in our database. You can also find out about relevant Genoptix Drugs and Medications on this site too.

Quick Search


Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Osteoporosis is a disease in which the bones become extremely porous, are subject to fracture, and heal slowly, occurring especially in women following menopause and often leading to curvature of the spine from vertebral collapse. Follow and track&n...

Corporate Database Quicklinks

Searches Linking to this Company Record